The company said that analyses and modeling of mutations in the variant suggest that they may weaken the effect of the treatment, but that studies using Omicron’s full sequences are incomplete.
Published: November 30, 2021 at 05:03PM
from NYT Health https://ift.tt/3EaJuoT